SCHEMBL19857713

SCHEMBL19857713

CN(C)c1ccc(C(=O)c2cc(Cl)ccc2N)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.53
HPGD P15428 3/20 0.53
ALDH1A1 P00352 3/20 0.53
RECQL P46063 1/20 0.53
NPC1 O15118 4/20 0.51
RAB9A P51151 1/20 0.51
TDP1 Q9NUW8 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
POLB P06746 2/20 0.50
TP53 P04637 1/20 0.50
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351799 0.85 RECQL (0.64) MAPTALDH1A1RECQLNPC1RAB9A
SCHEMBL10396907 0.83 MAPT (0.67) MAPTHPGDALDH1A1RECQLNPC1
SCHEMBL12653273 0.82 RECQL (0.60) MAPTALDH1A1RECQLNPC1RAB9A
SCHEMBL6332774 0.81 RECQL (0.58) MAPTHPGDALDH1A1RECQLNPC1
SCHEMBL31000389 0.80 RECQL (0.67) MAPTALDH1A1RECQLKMT2ASMN1; SMN2
SCHEMBL30484136 0.80 RECQL (0.67) MAPTALDH1A1RECQLKMT2ASMN1; SMN2
SCHEMBL145366 0.80 RECQL (0.67) MAPTALDH1A1RECQLKMT2ASMN1; SMN2
SCHEMBL25412059 0.80 HPGD (0.61) MAPTHPGDALDH1A1NPC1RAB9A
SCHEMBL2472942 0.80 RECQL (0.57) MAPTALDH1A1RECQLNPC1RAB9A
SCHEMBL2473605 0.80 MAPT (0.67) MAPTALDH1A1RECQLNPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 MAPT 1569/4885HPGD 3562/4885ALDH1A1 4269/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 MAPT 1569/4885HPGD 3562/4885ALDH1A1 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.